{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T14:37:06Z","timestamp":1793284626438,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008867","name":"Department of Education of Zhejiang Province","doi-asserted-by":"publisher","award":["Y202559796"],"award-info":[{"award-number":["Y202559796"]}],"id":[{"id":"10.13039\/501100008867","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ijbiomac.2026.154290","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T05:56:03Z","timestamp":1788155763000},"page":"154290","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P2","title":["A gellan gum-based in situ gel for prolonged ocular retention of ruxolitinib in dry eye disease"],"prefix":"10.1016","volume":"381","author":[{"given":"Qiao","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinghao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenying","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2026.154290_bb0005","article-title":"Global prevalence of dry eye: a systematic review and meta-analysis","volume":"49","author":"Xiao","year":"2025","journal-title":"Contact lens & anterior eye\u202f: the journal of the British Contact Lens Association"},{"key":"10.1016\/j.ijbiomac.2026.154290_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2022.106206","article-title":"Current trends in pharmaceutical treatment of dry eye disease: A review","volume":"175","author":"Mohamed","year":"2022","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2026.154290_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21239271","article-title":"Defining dry eye from a clinical perspective","volume":"21","author":"Tsubota","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2026.154290_bb0020","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jtos.2017.05.011","article-title":"TFOS DEWS II pathophysiology report","volume":"15","author":"Bron","year":"2017","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.ijbiomac.2026.154290_bb0025","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1517\/13543784.16.10.1525","article-title":"Next-generation calcineurin inhibitors for ophthalmic indications","volume":"16","author":"Anglade","year":"2007","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.ijbiomac.2026.154290_bb0030","first-page":"CD010051","article-title":"Topical cyclosporine A therapy for dry eye syndrome","volume":"9","author":"de Paiva","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ijbiomac.2026.154290_bb0035","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/jamaophthalmol.2024.0101","article-title":"Water-free cyclosporine ophthalmic solution vs vehicle for dry eye disease: A randomized clinical trial","volume":"142","author":"Peng","year":"2024","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.ijbiomac.2026.154290_bb0040","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/j.ophtha.2013.03.044","article-title":"Topical cyclosporine in the treatment of allergic conjunctivitis: a meta-analysis","volume":"120","author":"Wan","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ijbiomac.2026.154290_bb0045","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2026.2625552","article-title":"JAK inhibitor tofacitinib alleviates secretory dysfunction and Th17\/Treg imbalance in a Sj\u00f6gren's disease murine model","volume":"58","author":"Lin","year":"2026","journal-title":"Ann. Med."},{"key":"10.1016\/j.ijbiomac.2026.154290_bb0050","doi-asserted-by":"crossref","DOI":"10.1111\/srt.70276","article-title":"Vitiligo: ruxolitinib and other oral treatment options beyond ruxolitinib","volume":"31","author":"Ghani","year":"2025","journal-title":"Skin Res. Technol."},{"key":"10.1016\/j.ijbiomac.2026.154290_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/curroncol32060339","article-title":"Myelofibrosis: treatment options after ruxolitinib failure","volume":"32","author":"Stuckey","year":"2025","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.ijbiomac.2026.154290_bb0060","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1200\/JCO-24-02477","article-title":"Ruxolitinib in patients with corticosteroid-refractory or corticosteroid-dependent chronic graft-versus-host disease: 3-year final analysis of the phase III REACH3 study","volume":"43","author":"Zeiser","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ijbiomac.2026.154290_bb0065","doi-asserted-by":"crossref","DOI":"10.1111\/exd.70132","article-title":"Ruxolitinib alleviates inflammation and fortifies skin barrier function through dampening IL-13","volume":"34","author":"Koh","year":"2025","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.ijbiomac.2026.154290_bb0070","doi-asserted-by":"crossref","first-page":"6067","DOI":"10.1073\/pnas.1904532117","article-title":"Signaling mechanisms of growth hormone-releasing hormone receptor in LPS-induced acute ocular inflammation","volume":"117","author":"Liang","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijbiomac.2026.154290_bb0075","doi-asserted-by":"crossref","first-page":"eade9459","DOI":"10.1126\/sciadv.ade9459","article-title":"Inflammation of the retinal pigment epithelium drives early-onset photoreceptor degeneration in Mertk-associated retinitis pigmentosa","volume":"9","author":"Mercau","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ijbiomac.2026.154290_bb0080","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1167\/iovs.19-26928","article-title":"Therapeutic Effects of STAT3 Inhibition on Experimental Murine Dry Eye","volume":"60","author":"Qu","year":"2019","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ijbiomac.2026.154290_bb0085","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s40262-023-01225-7","article-title":"Pharmacokinetics and pharmacodynamics of ruxolitinib: a review","volume":"62","author":"Appeldoorn","year":"2023","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ijbiomac.2026.154290_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.126279","article-title":"Ion-activated gellan gum in situ gel for prolonged ocular administration of tofacitinib citrate: An innovative treatment approach for dry eye disease","volume":"685","author":"Chen","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2026.154290_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16081092","article-title":"Formulation of polymeric nanoparticles loading baricitinib as a topical approach in ocular application","volume":"16","author":"Beirampour","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2026.154290_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/polym12051114","article-title":"The use of poly(N-vinyl pyrrolidone) in the delivery of drugs: a review","volume":"12","author":"Franco","year":"2020","journal-title":"Polymers"},{"key":"10.1016\/j.ijbiomac.2026.154290_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.123819","article-title":"In-situ gel: A smart carrier for drug delivery","volume":"652","author":"Garg","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2026.154290_bb0110","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/713840402","article-title":"Ion-activated in situ gelling systems for sustained ophthalmic delivery of ciprofloxacin hydrochloride","volume":"10","author":"Balasubramaniam","year":"2003","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijbiomac.2026.154290_bb0115","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1186\/s12951-024-02668-1","article-title":"Preparation and in vivo and ex vivo studies of sirolimus nano-in-situ gel ophthalmic formulation","volume":"22","author":"Liu","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ijbiomac.2026.154290_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119093","article-title":"Gellan gum and its methacrylated derivatives as in situ gelling mucoadhesive formulations of pilocarpine: In vitro and in vivo studies","volume":"577","author":"Agibayeva","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2026.154290_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121379","article-title":"Development and optimization of Riluzole-loaded biodegradable nanoparticles incorporated in a mucoadhesive in situ gel for the posterior eye segment","volume":"612","author":"Esteruelas","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2026.154290_bb0130","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijpharm.2011.03.042","article-title":"Comparison of ion-activated in situ gelling systems for ocular drug delivery. Part 1: physicochemical characterisation and in vitro release","volume":"411","author":"Rupenthal","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2026.154290_bb0135","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.actbio.2025.08.039","article-title":"Structuring of gellan hydrogel enables the production of inherently antifibrotic, lubricating eye drops","volume":"205","author":"Moxon","year":"2025","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ijbiomac.2026.154290_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118734","article-title":"Novel in situ gelling ophthalmic drug delivery system based on gellan gum and hydroxyethylcellulose: Innovative rheological characterization, in vitro and in vivo evidence of a sustained precorneal retention time","volume":"574","author":"Destruel","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2026.154290_bb0145","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.bbrc.2018.03.112","article-title":"Zidovudine protects hyperosmolarity-stressed human corneal epithelial cells via antioxidant pathway","volume":"499","author":"Liu","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijbiomac.2026.154290_bb0150","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/s41598-020-80849-2","article-title":"A combination of CMC and \u03b1-MSH inhibited ROS activated NLRP3 inflammasome in hyperosmolarity stressed HCECs and scopolamine-induced dry eye rats","volume":"11","author":"Lv","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2026.154290_bb0155","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.2147\/JIR.S361541","article-title":"Long noncoding RNA MIAT regulates hyperosmotic stress-induced corneal epithelial cell injury via inhibiting the caspase-1-dependent pyroptosis and apoptosis in dry eye disease","volume":"15","author":"Li","year":"2022","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.ijbiomac.2026.154290_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15061646","article-title":"Corneal permeability and uptake of twenty-five drugs: species comparison and quantitative structure-permeability relationships","volume":"15","author":"Santana","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2026.154290_bb0165","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11095-012-0847-9","article-title":"Retina-choroid-sclera permeability for ophthalmic drugs in the vitreous to blood direction: quantitative assessment","volume":"30","author":"Haghjou","year":"2013","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijbiomac.2026.154290_bb0170","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/cbdd.14179","article-title":"Design, synthesis, and biological evaluation of novel ruxolitinib and baricitinib analogues for potential use against COVID-19","volume":"101","author":"Lin","year":"2023","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ijbiomac.2026.154290_bb0175","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.837369","article-title":"Identification of potent and selective JAK1 lead compounds through ligand-based drug design approaches","volume":"13","author":"Babu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2026.154290_bb0180","article-title":"Preparation and characterization of ion-sensitive brimonidine tartrate in situ gel for ocular delivery","volume":"16","author":"Xu","year":"2023","journal-title":"Pharmaceuticals (Basel, Switzerland)"},{"key":"10.1016\/j.ijbiomac.2026.154290_bb0185","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.preteyeres.2010.03.001","article-title":"Preservatives in eyedrops: the good, the bad and the ugly","volume":"29","author":"Baudouin","year":"2010","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ijbiomac.2026.154290_bb0190","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jtos.2024.08.001","article-title":"Preservatives and ocular surface disease: A review","volume":"34","author":"Kahook","year":"2024","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.ijbiomac.2026.154290_bb0195","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.2147\/OPTH.S211611","article-title":"The use of preservatives in dry eye drops","volume":"13","author":"Walsh","year":"2019","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.ijbiomac.2026.154290_bb0200","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/JCMA.0000000000000529","article-title":"Animal models of dry eye: Their strengths and limitations for studying human dry eye disease","volume":"84","author":"Chang","year":"2021","journal-title":"J. Chin. Med. Assoc."},{"key":"10.1016\/j.ijbiomac.2026.154290_bb0205","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.2147\/IJN.S403337","article-title":"Suppression of NLRP3\/Caspase-1\/GSDMD mediated corneal epithelium pyroptosis using melatonin-loaded liposomes to inhibit benzalkonium chloride-induced dry eye disease","volume":"18","author":"Lou","year":"2023","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ijbiomac.2026.154290_bb0210","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1124\/mol.105.018481","article-title":"Janus kinase-signal transducer and activator of transcription mediates phosphatidic acid-induced interleukin (IL)-1beta and IL-6 production","volume":"69","author":"Lee","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2026.154290_bb0215","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1097\/ICO.0b013e3181a16578","article-title":"Analysis of inflammatory cytokines in the tears of dry eye patients","volume":"28","author":"Massingale","year":"2009","journal-title":"Cornea"},{"key":"10.1016\/j.ijbiomac.2026.154290_bb0220","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.4049\/jimmunol.165.9.5227","article-title":"Inhibition of IL-6 and IL-10 signaling and STAT activation by inflammatory and stress pathways","volume":"165","author":"Ahmed","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijbiomac.2026.154290_bb0225","doi-asserted-by":"crossref","DOI":"10.3390\/gels11100787","article-title":"Optimized ion-sensitive hydrogels based on gellan gum and arabinogalactan for the treatment of dry eye disease","volume":"11","author":"Paganini","year":"2025","journal-title":"Gels"},{"key":"10.1016\/j.ijbiomac.2026.154290_bb0230","doi-asserted-by":"crossref","DOI":"10.1177\/20417314251342175","article-title":"Advances in hydrogels for capturing and neutralizing inflammatory cytokines","volume":"16","author":"Qin","year":"2025","journal-title":"J. Tissue Eng."},{"key":"10.1016\/j.ijbiomac.2026.154290_bb0235","doi-asserted-by":"crossref","first-page":"440","DOI":"10.4161\/cam.36224","article-title":"An introduction to the wound healing assay using live-cell microscopy","volume":"8","author":"Jonkman","year":"2014","journal-title":"Cell Adhes. Migr."},{"key":"10.1016\/j.ijbiomac.2026.154290_bb0240","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.actbio.2018.03.016","article-title":"Engineering interfacial migration by collective tuning of adhesion anisotropy and stiffness","volume":"72","author":"George","year":"2018","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ijbiomac.2026.154290_bb0245","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s13346-016-0339-2","article-title":"A comprehensive insight on ocular pharmacokinetics","volume":"6","author":"Agrahari","year":"2016","journal-title":"Drug Deliv. Transl. Res."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026042364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026042364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T14:17:44Z","timestamp":1793283464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813026042364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":49,"alternative-id":["S0141813026042364"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.154290","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A gellan gum-based in situ gel for prolonged ocular retention of ruxolitinib in dry eye disease","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.154290","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"154290"}}